Diabetes medications with cardiovascular protection: the likelihood of benefit from combination therapy increases further following new evidence during 2020

Autor:	Robert E.J. Ryder, Muhammad A. Abdul-Ghani, Ralph A. DeFronzo
Rok vydání:	2020
Předmět:	medicine.medical_specialty Combination therapy business.industry General Medicine Type 2 diabetes medicine.disease Internal medicine Heart failure Diabetes mellitus medicine Cardiology business Pioglitazone Stroke Glucagon-like peptide 1 receptor medicine.drug
Zdroj:	British Journal of Diabetes. 20:85-88
ISSN:	2397-6241 2397-6233
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e0ea6729a73a32d2befa9760db44895a https://doi.org/10.15277/bjd.2020.276 Zobrazit plný text záznamu